I would have expected a much more favorable response from the market on the oral Orally-Administered OCR-002 results. The PR was light on detail I guess..
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.